The Global AI In Medical Imaging Market was valued at USD 2.1 billion in 2025 and is estimated to grow at a CAGR of 23.9% to reach USD 19.6 billion by 2035.
The market is undergoing rapid transformation as deep learning technologies become deeply embedded into clinical imaging workflows, significantly improving diagnostic accuracy and operational efficiency. AI-enabled imaging solutions are increasingly being used to support early disease identification, reduce variability in diagnostic interpretation, and enhance treatment planning across oncology, neurology, and cardiology applications. Clinical validation studies and peer-reviewed research continue to demonstrate that advanced algorithms can achieve diagnostic performance levels comparable to experienced radiologists across multiple imaging modalities. Growing regulatory acceptance of AI-based diagnostic tools is accelerating hospital adoption and expanding reimbursement pathways in major healthcare systems. In parallel, rising investments from healthcare technology providers, imaging equipment manufacturers, academic institutions, and early-stage innovators are accelerating product development cycles and broadening application areas. Public sector research support, including funding initiatives from national biomedical agencies, continues to advance innovation in imaging reconstruction, cardiac diagnostics, and multi-modal data integration. As healthcare systems prioritize precision medicine and efficiency, AI-based imaging is becoming a core component of modern diagnostic infrastructure across global markets.
The cloud-based deployment segment accounted for 57.6% share in 2025. Cloud infrastructure is increasingly preferred due to its ability to support rapid algorithm deployment, scalable computing power, seamless software updates, and reduced upfront capital requirements. These advantages make cloud-based solutions especially suitable for healthcare facilities that lack large-scale on-premise computing systems, enabling broader adoption across diverse healthcare environments.
The hospital segment held a 56.1% share in 2025. Hospitals remain the primary end-use setting due to their advanced imaging infrastructure, high patient volumes, and strong institutional capacity for digital health investments. Large healthcare networks and academic medical centers are among the earliest adopters of enterprise-scale AI imaging systems, where high imaging throughput justifies the cost of integration, licensing, and workflow transformation.
North America AI in Medical Imaging Market accounted for 43.8% share in 2025, maintaining the largest regional share. The region’s leadership is supported by widespread deployment of regulatory-cleared AI imaging solutions, strong hospital IT investment, and established reimbursement structures that prioritize diagnostic accuracy and operational efficiency. The United States represents most regional revenue, while Canada continues to expand adoption through national-level digital health initiatives focused on advanced clinical imaging technologies.
Major companies operating in the global AI in medical imaging market include Philips Healthcare, GE HealthCare, Siemens Healthineers, Fujifilm Holdings, Canon Medical Systems, Aidoc, Viz.ai, Qure.ai, Lunit, RapidAI, Annalise.ai, Subtle Medical, Tempus Radiology, Rad AI, and Cleerly Inc. Companies in the AI in medical imaging market are strengthening their market position through continuous advancement of AI algorithms, expansion of clinical validation studies, and integration of solutions into existing hospital imaging workflows. Many players are prioritizing partnerships with hospitals, academic institutions, and healthcare networks to accelerate real-world deployment and improve algorithm training using large-scale imaging datasets. Strategic collaborations with medical device manufacturers and cloud service providers are enabling scalable and interoperable platforms. Companies are also focusing on regulatory approvals across multiple regions to expand commercialization opportunities.
This product will be delivered within 2-4 business days.
The market is undergoing rapid transformation as deep learning technologies become deeply embedded into clinical imaging workflows, significantly improving diagnostic accuracy and operational efficiency. AI-enabled imaging solutions are increasingly being used to support early disease identification, reduce variability in diagnostic interpretation, and enhance treatment planning across oncology, neurology, and cardiology applications. Clinical validation studies and peer-reviewed research continue to demonstrate that advanced algorithms can achieve diagnostic performance levels comparable to experienced radiologists across multiple imaging modalities. Growing regulatory acceptance of AI-based diagnostic tools is accelerating hospital adoption and expanding reimbursement pathways in major healthcare systems. In parallel, rising investments from healthcare technology providers, imaging equipment manufacturers, academic institutions, and early-stage innovators are accelerating product development cycles and broadening application areas. Public sector research support, including funding initiatives from national biomedical agencies, continues to advance innovation in imaging reconstruction, cardiac diagnostics, and multi-modal data integration. As healthcare systems prioritize precision medicine and efficiency, AI-based imaging is becoming a core component of modern diagnostic infrastructure across global markets.
The cloud-based deployment segment accounted for 57.6% share in 2025. Cloud infrastructure is increasingly preferred due to its ability to support rapid algorithm deployment, scalable computing power, seamless software updates, and reduced upfront capital requirements. These advantages make cloud-based solutions especially suitable for healthcare facilities that lack large-scale on-premise computing systems, enabling broader adoption across diverse healthcare environments.
The hospital segment held a 56.1% share in 2025. Hospitals remain the primary end-use setting due to their advanced imaging infrastructure, high patient volumes, and strong institutional capacity for digital health investments. Large healthcare networks and academic medical centers are among the earliest adopters of enterprise-scale AI imaging systems, where high imaging throughput justifies the cost of integration, licensing, and workflow transformation.
North America AI in Medical Imaging Market accounted for 43.8% share in 2025, maintaining the largest regional share. The region’s leadership is supported by widespread deployment of regulatory-cleared AI imaging solutions, strong hospital IT investment, and established reimbursement structures that prioritize diagnostic accuracy and operational efficiency. The United States represents most regional revenue, while Canada continues to expand adoption through national-level digital health initiatives focused on advanced clinical imaging technologies.
Major companies operating in the global AI in medical imaging market include Philips Healthcare, GE HealthCare, Siemens Healthineers, Fujifilm Holdings, Canon Medical Systems, Aidoc, Viz.ai, Qure.ai, Lunit, RapidAI, Annalise.ai, Subtle Medical, Tempus Radiology, Rad AI, and Cleerly Inc. Companies in the AI in medical imaging market are strengthening their market position through continuous advancement of AI algorithms, expansion of clinical validation studies, and integration of solutions into existing hospital imaging workflows. Many players are prioritizing partnerships with hospitals, academic institutions, and healthcare networks to accelerate real-world deployment and improve algorithm training using large-scale imaging datasets. Strategic collaborations with medical device manufacturers and cloud service providers are enabling scalable and interoperable platforms. Companies are also focusing on regulatory approvals across multiple regions to expand commercialization opportunities.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology & Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, by Deployment, 2022-2035 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Modality, 2022-2035 ($ Mn)
Chapter 7 Market Estimates and Forecast, by Indication, 2022-2035 ($ Mn)
Chapter 8 Market Estimates and Forecast, by Application, 2022-2035 ($ Mn)
Chapter 9 Market Estimates and Forecast, by End Use, 2022-2035 ($ Mn)
Chapter 10 Market Estimates and Forecast, by Region, 2022-2035 ($ Mn)
Chapter 11 Company Profiles
Companies Mentioned
- GE HealthCare
- Siemens Healthineers
- Philips Healthcare
- Canon Medical Systems
- Fujifilm Holdings
- Aidoc
- Viz.ai
- RapidAI
- Tempus Radiology
- Lunit
- Qure.ai
- Annalise.ai
- Subtle Medical
- Rad AI
- Cleerly
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 137 |
| Published | June 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 2.1 Billion |
| Forecasted Market Value ( USD | $ 19.6 Billion |
| Compound Annual Growth Rate | 23.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
